PMID: 9541440Apr 16, 1998Paper

Intraoperative mitomycin C and the corneal endothelium

Acta Ophthalmologica Scandinavica
R SihotaH C Agarwal

Abstract

Mitomycin-C (MMC) is a useful adjunct to high risk glaucoma surgery. No clinical data regarding the deleterious effect of mitomycin-C on the corneal endothelial cells are available. Thirty eyes of 28 adult patients with high risk glaucomas were randomized to three groups. Group-I underwent a trabeculectomy alone, Group II, trabeculectomy with intraoperative 0.2mg/ml MMC and Group III, trabeculectomy with intraoperative 0.4mg/ml MMC. Preoperative and 3-month postoperative corneal endothelial cell counts were analysed. The percentage cell loss in Group I was 3.73+/-2.73%, in Group II 13.90+/-4.69% and in Group III 14.52+/-7.8%. Statistical analysis revealed a significant difference in cell loss between Group I and Group II and Group I and Group III, but not between Group II and Group III. There is a significant loss of corneal endothelial cells three months after trabeculectomy with adjunctive MMC.

Citations

Jul 11, 2003·Progress in Retinal and Eye Research·Nancy C Joyce
Oct 26, 1999·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·K Y WuC W Chen
Nov 28, 2012·Journal of Cataract and Refractive Surgery·Ahmad ShojaeiMedi Eslani
Oct 11, 2011·American Journal of Ophthalmology·Naveed NilforushanNariman Nassiri
Jan 18, 2011·American Journal of Ophthalmology·Ahmad KheirkhahMahmoud Jabbarvand Behrouz
Aug 26, 2009·American Journal of Ophthalmology·Yasar Sakarya, Rabia Sakarya
Sep 9, 2011·Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye·Nariman NassiriGholam A Peyman
May 24, 2008·Journal of Cataract and Refractive Surgery·Nader NassiriNariman Nassiri
May 19, 2007·American Journal of Ophthalmology·Vasilios F DiakonisMarinos M Markomanolakis
Feb 5, 2008·American Journal of Ophthalmology·Anita PandaShalini Mohan
Nov 11, 2008·American Journal of Ophthalmology·Irit BaharAllan R Slomovic
Aug 18, 2004·Journal of Cataract and Refractive Surgery·Shu-Wen Chang
Aug 9, 2005·American Journal of Ophthalmology·Alexandros N StangosGordana Sunaric-Megevand
Aug 29, 2006·American Journal of Ophthalmology·Alberto J MoralesArturo S Chayet
Aug 2, 2005·Experimental Eye Research·Nancy C Joyce
Jun 28, 2014·Experimental Eye Research·Sriniwas SriramGregory Schultz
Feb 23, 2013·Journal of Glaucoma·Nitin Anand, Chunxiao Bong
Oct 12, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Antigoni KoukkoulliNitin Anand
Jun 4, 2008·Cornea·Rahamim AvisarDov Weinberger
Sep 23, 2009·Cornea·Consuelo Pérez-RicoMiguel Angel Teus
Jan 6, 2018·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Naoki OkumuraKazuhiko Mori
Oct 13, 2018·Journal of Glaucoma·Tomomi HigashideKazuhisa Sugiyama
Dec 19, 2008·Journal of Glaucoma·Thomas Storr-PaulsenAllan Storr-Paulsen
Oct 28, 1999·Current Opinion in Ophthalmology·N S BorisuthT Krupin
Jun 16, 2019·The British Journal of Ophthalmology·Kazuyuki HirookaYoshiaki Kiuchi
Jan 14, 2020·International Ophthalmology·Naoki TojoAtsushi Hayashi
May 27, 2020·European Journal of Ophthalmology·Ali OlgunS Yekta Sendul
Aug 3, 2020·Ophthalmology. Glaucoma·Adam J WeinerAsher Weiner
Oct 27, 2020·Journal of Glaucoma·Tony RealiniMalik Y Kahook
May 15, 2003·Survey of Ophthalmology·Paul J Lama, Robert D Fechtner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.